pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-664a |
Genomic Coordinates | chr1: 220200538 - 220200619 |
Description | Homo sapiens miR-664 stem-loop |
Comment | This miRNA sequence overlaps an annotated snoRNA, ACA38b. However, both miR and miR* sequences are identified in reference , and the sequence is homologous with rat mir-664. |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-664a-3p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 49| UAUUCAUUUAUCCCCAGCCUACA |71 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HLF | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | HLF, PAR bZIP transcription factor | ||||||||||||||||||||
Transcript | NM_002126 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HLF | |||||||||||||||||||||
3'UTR of HLF (miRNA target sites are highlighted) |
>HLF|NM_002126|3'UTR 1 GATGGCATTTTTGCAGGCTGGCTTTGGAATAGATGGACAGTTTGTTTCCTGTCTGATAGCACCACACGCAAACCAACCTT 81 TCTGACATCAGCACTTTACCAGAGGCATAAACACAACTGACTCCCATTTTGGTGTGCATCTGTGTGTGTGTGCGTGTATA 161 TGTGCTTGTGCTCATGTGTGTGGTCAGCGGTATGTGCGTGTGCGTGTTCCTTTGCTCTTGCCATTTTAAGGTAGCCCTCT 241 CATCGTCTTTTAGTTCCAACAAAGAAAGGTGCCATGTCTTTACTAGACTGAGGAGCCCTCTCGCGGGTCTCCCATCCCCT 321 CCCTCCTTCACTCCTGCCTCCTCAGCTTTGCTTCATGTTCGAGCTTACCTACTCTTCCAGGACTCTCTGCTTGGATTCAC 401 TAAAAAGGGCCCTGGTAAAATAGTGGATCTCAGTTTTTAAGAGTACAAGCTCTTGTTTCTGTTTAGTCCGTAAGTTACCA 481 TGCTAATGAGGTGCACACAATAACTTAGCACTACTCCGCAGCTCTAGTCCTTTATAAGTTGCTTTCCTCTTACTTTCAGT 561 TTTGGTGATAATCGTCTTCAAATTAAAGTGCTGTTTAGATTTATTAGATCCCATATTTACTTACTGCTATCTACTAAGTT 641 TCCTTTTAATTCTACCAACCCCAGATAAGTAAGAGTACTATTAATAGAACACAGAGTGTGTTTTTGCACTGTCTGTACCT 721 AAAGCAATAATCCTATTGTACGCTAGAGCATGCTGCCTGAGTATTACTAGTGGACGTAGGATATTTTCCCTACCTAAGAA 801 TTTCACTGTCTTTTAAAAAACAAAAAGTAAAGTAATGCATTTGAGCATGGCCAGACTATTCCCTAGGACAAGGAAGCAGA 881 GGGAAATGGGAGGTCTAAGGATGAGGGGTTAATTTATCAGTACATGAGCCAAAAACTGCGTCTTGGATTAGCCTTTGACA 961 TTGATGTGTTCGGTTTTGTTGTTCCCCTTCCCTCACACCCTGCCTCGCCCCCACTTTTCTAGTTAACTTTTTCCATATCC 1041 CTCTTGACATTCAAAACAGTTACTTAAGATTCAGTTTTCCCACTTTTTGGTAATATATATATTTTTGTGAATTATACTTT 1121 GTTGTTTTTAAAAAGAAAATCAGTTGATTAAGTTAATAAGTTGATGTTTTCTAAGGCCCTTTTTCCTAGTGGTGTCATTT 1201 TTGAATGCCTCATAAATTAATGATTCTGAAGCTTATGTTTCTTATTCTCTGTTTGCTTTTGAACGTATGTGCTCTTATAA 1281 AGTGGACTTCTGAAAAATGAATGTAAAAGACACTGGTGTATCTCAGAAGGGGATGGTGTTGTCACAAACTGTGGTTAATC 1361 CAATCAATTTAAATGTTTACTATAGACCAAAAGGAGAGATTATTAAATCGTTTAATGTTTATACAGAGTAATTATAGGAA 1441 GTTCTTTTTTGTACAGTATTTTTCAGATATAAATACTGACAATGTATTTTGGAAGACATATATTATATATAGAAAAGAGG 1521 AGAGGAAAACTATTCCATGTTTTAAAATTATATAGCAAAGATATATATTCACCAATGTTGTACAGAGAAGAAGTGCTTGG 1601 GGGTTTTTGAAGTCTTTAATATTTTAAGCCCTATCACTGACACATCAGCATGTTTTCTGCTTTAAATTAAAATTTTATGA 1681 CAGTATCGAGGCTTGTGATGACGAATCCTGCTCTAAAATACACAAGGAGCTTTCTTGTTTCTTATTAGGCCTCAGAAAGA 1761 AGTCAGTTAACGTCACCCAAAAGCACAAAATGGATTTTAGTCAAATATTTATTGGATGATACAGTGTTTTTTAGGAAAAG 1841 CATCTGCCACAAAAATGTTCACTTCGAAATTCTGAGTTCCTGGAATGGCACGTTGCTGCCAGTGCCCCAGACAGTTCTTT 1921 TCTACCCTGCGGGCCCGCACGTTTTATGAGGTTGATATCGGTGCTATGTGTTTGGTTTATAATTTGATAGATGTTTGACT 2001 TTAAAGATGATTGTTCTTTTGTTTCATTAAGTTGTAAAATGTCAAGAAATTCTGCTGTTACGACAAAGAAACATTTTACG 2081 CTAGATTAAAATATCCTTTCATCAATGGGATTTTCTAGTTTCCTGCCTTCAGAGTATCTAATCCTTTAATGATCTGGTGG 2161 TCTCCTCGTCAATCCATCAGCAATGCTTCTCTCATAGTGTCATAGACTTGGGAAACCCAACCAGTAGGATATTTCTACAA 2241 GGTGTTCATTTTGTCACAAGCTGTAGATAACAGCAAGAGATGGGGGTGTATTGGAATTGCAATACATTGTTCAGGTGAAT 2321 AATAAAATCAAAAACTTTTGCAATCTTAAGCAGAGATAAATAAAAGATAGCAATATGAGACACAGGTGGACGTAGAGTTG 2401 GCCTTTTTACAGGCAAAGAGGCGAATTGTAGAATTGTTAGATGGCAATAGTCATTAAAAACATAGAAAAATGATGTCTTT 2481 AAGTGGAGAATTGTGGAAGGATTGTAACATGGACCATCCAAATTTATGGCCGTATCAAATGGTAGCTGAAAAAACTATAT 2561 TTGAGCACTGGTCTCTCTTGGAATTAGATGTTTATATCAAATGAGCATCTCAAATGTTTTCTGCAGAAAAAAATAAAAAG 2641 ATTCTAATAAAATGTATTCTCTTGTGTGCCAGGAGAGGTTTCAGAAACCTACCTCGTCTTACAAATTTAAACACTTTGGA 2721 GTCTGTACAGGTGCCTTATATGTAGGTCATTGTCACGATACACACACACGAACACTCCCTCTGGACTGGCTGCCTCTCCA 2801 TCCAGGGCAGTTAACTAGCAAACAAGGCAGATCTGCTTCATGGAGCGGGAGGCCATGGCTTGACTCTGAGTGATTTGGGT 2881 CAACCGGAGTCAGACGCATGTCTGCACGCTGCAGCTATTATGAGAGTCCCTTTGTCATTTTTCACCTTTTCATCCTAAGC 2961 ATCTTTCAGAGATTAATTATTTGGCCATTAACAATGAATCCAAATCATATCATACTGACATCATCTAGACATGATTTGGA 3041 AGGAACAGCTTAGGACCTCCTGATGAGGTCACATTGTTGTTTCTTTTAACTAGACTTGGCAAAGAAAGGCAAAAATTGAC 3121 CAGCCTATCTTTCTGCTGGTGCTGCCTTAAGGAGGTAGTTTGTTGAGGGGAGGGCTGTAGATCATTACTTCTTTCTCTTC 3201 AGGAAGTGGCCACTTTGAACCATTCAAATACCACATTAGGCAAGACTGTGATAGGCCTTTTGTCTTCAAATACAACAGGC 3281 CTCCACTGACCCATCCCTCAAAGCAGAAGGACCCTTTGAGGAGAGTACAGATGGGATTCCACAGTGGGGTGGGTGGAATG 3361 GAAACCTGTACTAGACCACCCAGAGGTTCCTTCTAACCCACTGGTTTGGTGGGGAACTCACAGTAATTCCAAATGTACAA 3441 TCAGATGTCTAGGGTCTGTTTTCGGAAGAAGCAAGAATTATCAGTGGCACCCTCCCCACTGCCCCCAGTGTAAAACAATA 3521 GACATTCTGTGAAATGCAAAGCTATTCTTTGGTTTTTCTAGTAGTTTATCTCATTTTACCCTATTCTTCCTTTAAGGAAA 3601 ACTCAATCTTTATCACAGTCAATTAGAGCGATCCCAAGGCATGGGACCAGGCCTGCTTGCCTATGTGTGATGGCAATTGG 3681 AGATCTGGATTTAGCACTGGGGTCTCAGCACCCTGCAGGTGTCTGAGACTAAGTGATCTGCCCTCCAGGTGGCGATCACC 3761 TTCTGCTCCTAGGTACCCCCACTGGCAAGGCCAAGGTCTCCTCCACGTTTTTTCTGCAATTAATAATGTCATTTAAAAAA 3841 TGAGCAAAGCCTTATCCGAATCGGATATAGCAACTAAAGTCAATACATTTTGCAGGAGGCTAAGTGTAAGAGTGTGTGTG 3921 TGTGTGTGTGCGTGCATGTGTGTGTGTGTGTATGTGTGTGAATAAGTCGACATAAAGTCTTTAATTTTGAGCACCTTACC 4001 AAACATAACAATAATCCATTATCCTTTTGGCAACACCACAAAGATCGCATCTGTTAAACAGGTACAAGTTGACATGAGGT 4081 TAGTTTAATTGTACACCATGATATTGGTGGTATTTATGCTGTTAAGTCCAAACCTTTATCTGTCTGTTATTCTTAATGTT 4161 GAATAAACTTTGAATTTTTTCCTTTCAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-3 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000226067.5 | 3UTR | UUGGCCAUUAACAAUGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
88 hsa-miR-664a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035824 | HIAT1 | major facilitator superfamily domain containing 14A | 1 | 1 | ||||||||
MIRT035826 | FUS | FUS RNA binding protein | 1 | 1 | ||||||||
MIRT069432 | SIVA1 | SIVA1 apoptosis inducing factor | 2 | 2 | ||||||||
MIRT071494 | CALM1 | calmodulin 1 | 2 | 2 | ||||||||
MIRT100410 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 2 | ||||||||
MIRT143469 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT191113 | ARF6 | ADP ribosylation factor 6 | 2 | 2 | ||||||||
MIRT235584 | SNRPB2 | small nuclear ribonucleoprotein polypeptide B2 | 2 | 8 | ||||||||
MIRT339131 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT437450 | MAT1A | methionine adenosyltransferase 1A | 1 | 1 | ||||||||
MIRT442234 | BTD | biotinidase | 2 | 2 | ||||||||
MIRT443321 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT443769 | HLF | HLF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT444352 | KIAA1211 | KIAA1211 | 2 | 2 | ||||||||
MIRT456348 | OLIG3 | oligodendrocyte transcription factor 3 | 2 | 8 | ||||||||
MIRT458866 | CD55 | CD55 molecule (Cromer blood group) | 2 | 2 | ||||||||
MIRT466169 | TMED5 | transmembrane p24 trafficking protein 5 | 2 | 2 | ||||||||
MIRT470445 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 6 | ||||||||
MIRT471524 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT477744 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT482885 | CACNA2D3 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | 2 | 2 | ||||||||
MIRT496336 | PTPRT | protein tyrosine phosphatase, receptor type T | 2 | 2 | ||||||||
MIRT497703 | ARL6IP6 | ADP ribosylation factor like GTPase 6 interacting protein 6 | 2 | 2 | ||||||||
MIRT499068 | CTBP1 | C-terminal binding protein 1 | 2 | 4 | ||||||||
MIRT500296 | ZNF667 | zinc finger protein 667 | 2 | 8 | ||||||||
MIRT500506 | ZBTB34 | zinc finger and BTB domain containing 34 | 2 | 8 | ||||||||
MIRT501964 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 2 | ||||||||
MIRT505457 | SUB1 | SUB1 homolog, transcriptional regulator | 2 | 4 | ||||||||
MIRT505955 | RAN | RAN, member RAS oncogene family | 2 | 6 | ||||||||
MIRT507512 | DYNLL2 | dynein light chain LC8-type 2 | 2 | 4 | ||||||||
MIRT512953 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT520450 | TSPAN2 | tetraspanin 2 | 2 | 6 | ||||||||
MIRT525997 | MAGEL2 | MAGE family member L2 | 2 | 2 | ||||||||
MIRT526424 | ZNF695 | zinc finger protein 695 | 2 | 2 | ||||||||
MIRT527364 | KRTAP13-2 | keratin associated protein 13-2 | 2 | 2 | ||||||||
MIRT529612 | H1F0 | H1 histone family member 0 | 2 | 2 | ||||||||
MIRT529811 | TMLHE | trimethyllysine hydroxylase, epsilon | 2 | 2 | ||||||||
MIRT530971 | EXO5 | exonuclease 5 | 2 | 4 | ||||||||
MIRT531294 | WNT7A | Wnt family member 7A | 2 | 2 | ||||||||
MIRT531870 | POF1B | premature ovarian failure, 1B | 2 | 2 | ||||||||
MIRT532116 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT533534 | TPR | translocated promoter region, nuclear basket protein | 2 | 2 | ||||||||
MIRT545934 | ZBTB44 | zinc finger and BTB domain containing 44 | 2 | 4 | ||||||||
MIRT546649 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT548063 | GNS | glucosamine (N-acetyl)-6-sulfatase | 2 | 2 | ||||||||
MIRT548288 | FAM3C | family with sequence similarity 3 member C | 2 | 4 | ||||||||
MIRT551018 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT551139 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT552398 | ZNF487P | zinc finger protein 487 | 1 | 1 | ||||||||
MIRT555640 | PHIP | pleckstrin homology domain interacting protein | 2 | 4 | ||||||||
MIRT556267 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT558864 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT559239 | BEND4 | BEN domain containing 4 | 2 | 2 | ||||||||
MIRT559438 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT559793 | ZNF415 | zinc finger protein 415 | 2 | 2 | ||||||||
MIRT562572 | CBX6 | chromobox 6 | 2 | 2 | ||||||||
MIRT562741 | ZNF83 | zinc finger protein 83 | 2 | 2 | ||||||||
MIRT564737 | ZNF23 | zinc finger protein 23 | 2 | 2 | ||||||||
MIRT565174 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT566301 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | 2 | 2 | ||||||||
MIRT571656 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT610720 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT611486 | ADCYAP1R1 | ADCYAP receptor type I | 2 | 4 | ||||||||
MIRT617118 | KANK2 | KN motif and ankyrin repeat domains 2 | 2 | 2 | ||||||||
MIRT617836 | SIGLEC10 | sialic acid binding Ig like lectin 10 | 2 | 2 | ||||||||
MIRT636145 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT638060 | YAE1D1 | Yae1 domain containing 1 | 2 | 4 | ||||||||
MIRT640159 | CDK13 | cyclin dependent kinase 13 | 2 | 2 | ||||||||
MIRT644257 | WEE2 | WEE1 homolog 2 | 2 | 2 | ||||||||
MIRT646838 | TLDC1 | TBC/LysM-associated domain containing 1 | 2 | 2 | ||||||||
MIRT653074 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 2 | 2 | ||||||||
MIRT657671 | GPR26 | G protein-coupled receptor 26 | 2 | 2 | ||||||||
MIRT660601 | AP3M2 | adaptor related protein complex 3 mu 2 subunit | 2 | 2 | ||||||||
MIRT668908 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT672685 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT680977 | DCAF17 | DDB1 and CUL4 associated factor 17 | 2 | 2 | ||||||||
MIRT682271 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT702058 | RNMT | RNA guanine-7 methyltransferase | 2 | 2 | ||||||||
MIRT707786 | UNK | unkempt family zinc finger | 2 | 2 | ||||||||
MIRT709238 | RANGAP1 | Ran GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT710119 | MED23 | mediator complex subunit 23 | 2 | 2 | ||||||||
MIRT710675 | ADAP2 | ArfGAP with dual PH domains 2 | 2 | 2 | ||||||||
MIRT712884 | NIPBL | NIPBL, cohesin loading factor | 2 | 2 | ||||||||
MIRT719015 | HPGD | 15-hydroxyprostaglandin dehydrogenase | 2 | 2 | ||||||||
MIRT723323 | COLEC10 | collectin subfamily member 10 | 2 | 2 | ||||||||
MIRT724947 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT725535 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT734156 | FHL1 | four and a half LIM domains 1 | 3 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|